Publication Name	World Journal of Cardiology
Manuscript ID	82958
Country	Italy

Received	2023-01-03 11:37
Peer-Review Started	2023-01-03 11:38
To Make the First Decision
Return for Revision	2023-03-15 02:17
Revised	2023-03-27 12:51
Second Decision	2023-04-07 02:31
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2023-04-07 08:03
Articles in Press	2023-04-07 08:03
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-04-18 05:58
Publish the Manuscript Online	2023-04-20 08:57

ISSN	1949-8462 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Minireviews
Article Title	Optimization of the pharmacological therapy in patients with poly-vascular disease: A multidisciplinary approach
Manuscript Source	Invited Manuscript
All Author List	Rocco Gioscia, Claudio Castagno, Monica Verdoia, Barbara Conti, Enzo Forliti and Andrea Rognoni
Funding Agency and Grant Number
Corresponding Author	Andrea Rognoni, MD, Chief Physician, Department of Cardiology, Nuovo Ospedale Degli Infermi, via dei Ponderanesi, Biella 13900, Italy. andrea.rognoni@aslbi.piemonte.it
Key Words	Poly-vascular disease; Coronary artery disease; Atherosclerosis; Antitrombotic therapy; Cholesterol; Statins; PCSK9
Core Tip	Patients with concomitant coronary and peripheral artery disease, i.e. poly-vascular disease, represent a subset of patients with higher risk and worse prognosis. In these patients antithrombotic and antilipidemic drugs should be tailored in order to achieve the most aggressive combination tolerated for each patient. Multidisciplinary approach, involving both a cardiologist and vascular surgeon, combining different therapeutic goals and perspectives, could provide additional benefits in the correct management of poly-vascular patients.
Publish Date	2023-04-20 08:57
Citation	Gioscia R, Castagno C, Verdoia M, Conti B, Forliti E, Rognoni A. Optimization of the pharmacological therapy in patients with poly-vascular disease: A multidisciplinary approach. World J Cardiol 2023; 15(4): 142-153
URL	https://www.wjgnet.com/1949-8462/full/v15/i4/142.htm
DOI	https://dx.doi.org/10.4330/wjc.v15.i4.142

Full Article (PDF)	WJC-15-142.pdf
Full Article (Word)	WJC-15-142.docx
Manuscript File	82958_Auto_Edited-LJH-JLW.docx
Answering Reviewers	82958-Answering reviewers.pdf
Audio Core Tip	82958-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	82958-Conflict-of-interest statement.pdf
Copyright License Agreement	82958-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	82958-Language certificate.pdf
Peer-review Report	82958-Peer-review(s).pdf
Scientific Misconduct Check	82958-Bing-Liu JH-2.png
Scientific Misconduct Check	82958-CrossCheck.png
Scientific Editor Work List	82958-Scientific editor work list.pdf
CrossCheck Report	82958-CrossCheck report.pdf